United States · FDA National Drug Code directory
Apidra
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0088-2500_6be54063-6912-4810-b1c7-dfca969224d8
- Product NDC
- 0088-2500
- Form
- INJECTION, SOLUTION
- Composition / generic term
- insulin glulisine
- Labeler
- sanofi-aventis U.S. LLC
- Marketing category
- BLA
- Marketing start / end (source format)
- 20090224
- Source listing expiry
- 20261231
Source-listed ingredients
- INSULIN GLULISINE — 100 [iU]/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, GLASS in 1 CARTON (0088-2500-33) / 10 mL in 1 VIAL, GLASS · 0088-2500-33
- 1 VIAL, GLASS in 1 CARTON (0088-2500-34) / 10 mL in 1 VIAL, GLASS · 0088-2500-34
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →